First recurrent infection with vancomycin-resistant enterococcus from Turkey

Journal of Infection

Volumn 53, Issue 3, 2006, Pages

  Citak, Elvan Caglar ^a   Oguz, Aynur ^a   Karadeniz, Ceyda ^a   Okur, Visal ^a   Basustaoglu, Ahmet ^b   Arman, Dilek ^a  

^a GAZI UNIVERSITY FACULTY OF MEDICINE   (Turkey)

^b GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Children; Febrile neutropenia; Neuroblastoma; Recurrence; Vancomycin resistant enterococcus

Indexed keywords

AMIKACIN; CEFEPIME; CIPROFLOXACIN; CISPLATIN; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; MEROPENEM; TEICOPLANIN; VANCOMYCIN; VINCRISTINE;

ABDOMINAL PAIN; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM IDENTIFICATION; CASE REPORT; CONVULSION; ENTEROCOCCAL INFECTION; ENTEROCOCCUS FAECIUM; FEBRILE NEUTROPENIA; FEMALE; GAIT DISORDER; HEPATOMEGALY; HUMAN; MUSCLE WEAKNESS; NEUROBLASTOMA; PARAPLEGIA; PRESCHOOL CHILD; RECURRENT INFECTION; SENSORY DYSFUNCTION; TURKEY (REPUBLIC); URINARY TRACT INFECTION; VANCOMYCIN RESISTANT ENTEROCOCCUS;

ANTI-BACTERIAL AGENTS; BACTEREMIA; CHILD, PRESCHOOL; CIPROFLOXACIN; ENTEROCOCCUS FAECIUM; FEMALE; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; TURKEY; VANCOMYCIN RESISTANCE;

EID: 33747153571     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2005.11.021     Document Type: Article

References (23)

1. Moellering Jr. R.C. Emergence of enterococcus as a significant pathogen. Clin Infect Dis 14 (1992) 1173-1176
2. Grayson M.L., Eliopoulos G.M., Wennersten C.B., Ruoff K.L., De Girolami P.C., Ferraro M.J., et al. Increasing resistance to β-lactam antibiotics among clinical isolates of Enterococcus faecium: a 22-year review at one institution. Antimicrob Agents Chemother 35 (1991) 2180-2184
3. Se O., Chirurgi V.A., Goldberg A.A., Aiken S., and McCabe R.E. Ampicillin-resistant enterococcal species in an acute-care hospital. Antimicrob Agents Chemother 34 (1990) 1821-1823
4. Jones R.N. Gram-positive superinfections following beta-lactam chemotherapy: the significance of enterococcus. Infection 13 (1985) 81-88
5. Yu V.L. Enterococcal superinfection and colonization after therapy with moxalactam: a new broad-spectrum antibiotic. Ann Intern Med 94 (1981) 784-785
6. Murray B.E. Vancomycin-resistant enterococcal infections. N Engl J Med 342 (1999) 710-721
7. van den Braak N., Ott A., van Belkum A., Kluytmans J.A., Koeleman J.G., Spanjaard L., et al. Prevalence and determinants of fecal colonization with vancomycin resistant enterococcus in hospitalized patients in the Netherlands. Infect Control Hosp Epidemiol 21 (2000) 520-524
8. Ozkuyumcu C. Resistant enterococci: prevalence and factors associated with colonization in a Turkish university hospital. Acta Microbiol Pol 48 (1999) 203-207
9. Schouten M.A., Hoogkamp-Korstanje J.A., Meis J.F., Voss A., and European VRE Study Group. Prevalence of vancomycin-resistant enterococci in Europe. Eur J Clin Microbiol Infect Dis 19 (2000) 816-822
10. Basustaoglu A., Aydogan H., Beyan C., Yalcin A., and Unal S. First glycopeptide-resistant Enterococcus faecium isolate from blood culture in Ankara, Turkey. Emerging Infect Dis 7 (2001) 160-161
11. Kacmaz B., and Aksoy A. Antimicrobial resistance of enterococci in Turkey. Int J Antimicrob Agents 25 (2005) 535-538
12. Edmond M.B., Ober J.F., Weinbaum D.L., Pfaller M.A., Hwang T., Sanford M.D., et al. Vancomycin-resistant Enterococcus faecium bacteremia: risk factors for infection. Clin Infect Dis 20 (1995) 1126-1133
13. Zaas A.K., Song X., Tucker P., and Perl T.M. Risk factors for development of vancomycin-resistant enterococcal bloodstream infection in patients with cancer who are colonized with vancomycin-resistant enterococci. Clin Infect Dis 35 (2002) 1139-1146
14. Roghmann M.C., Qaiyumi S., Johnson J.A., Schwalbe R., Morris Jr. J.G., et al. Recurrent vancomycin-resistant Enterococcus faecium bacteremia in a leukemia patient who was persistently colonized with vancomycin-resistant enterococci for two years. Clin Infect Dis 24 (1997) 514-515
15. Baran Jr. J., Riederer K.M., Ramanathan J., Khatib R., et al. Recurrent vancomycin-resistant Enterococcus bacteremia: prevalence, predisposing factors and strain relatedness. Clin Infect Dis 32 (2001) 1381-1383
16. Papp L., McNeeley D.F., Projan S.J., Bradford P.A., Frost A., and Nesin M. Recurrent episodes of shock-like syndrome caused by the same strain of vancomycin-resistant Enterococcus faecium in a pediatric patient. Microb Drug Resist 9 (2003) 307-312
17. Roghmann M.C., Qaiyumi S., Johnson J.A., Schwalbe R., and Morris Jr. J.G. Recurrent vancomycin-resistant Enterococcus faecium bacteremia in a leukemia patient who was persistently colonized with vancomycin-resistant enterococci for 2y. Clin Infect Dis 24 (1997) 514-515
18. Yeh K.M., Lu J.J., Siu L.K., Peng M.Y., and Chang F.Y. Phenotypes and genotypes of vancomycin-resistant enterococci isolated during long-term follow-up in a patient with recurrent bacteremia and colonization. J Microbiol Immunol Infect 35 (2002) 243-248
19. Elsner H.A., Drews D., Burdelski M., and Kaulfers P.M. Recurrent septicemias with Enterococcus faecium. Infection 25 (1997) 127-128
20. Cheng A.C., Murdoch D.R., Harrell L.J., and Reller L.B. Clinical profile and strain relatedness of recurrent enterococcal bacteremia. Scand J Infect Dis 37 (2005) 642-646
21. Kauffman C.A. Therapeutic and preventative options for the management of vancomycin-resistant enterococcal infections. J Antimicrob Chemother 51 Suppl. S3 (2003) iii23-iii30
22. Udo E.E., Al-Sweih N., Phillips O.A., and Chugh T.D. Species prevalence and antibacterial resistance of enterococci isolated in Kuwait hospitals. J Med Microbiol 52 (2003) 163-168
23. Kapoor L., Randhawa V.S., and Deb M. Antimicrobial resistance of enterococcal blood isolates at a pediatric care hospital in India. Jpn J Infect Dis 58 (2005) 101-103